Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program

Q32 Bio Inc. (QTTB) PT Lowered to $20 at Oppenheimer

December 11, 2024 6:37 AM EST

Oppenheimer analyst Jay Olson lowered the price target on Q32 Bio Inc. (NASDAQ: QTTB) to $20.00 (from $80.00) while maintaining a Outperform rating.

The analyst comments "QTTB reported negative AD but positive AA results along with an update on clinical development plans for bempikibart. While... More